Skip navigation
Use este identificador para citar ou linkar para este item: http://repositorio.unb.br/handle/10482/33985
Arquivos associados a este item:
Arquivo Descrição TamanhoFormato 
ARTIGO_PD-L1MayMediateT-Cell.pdf2,1 MBAdobe PDFVisualizar/Abrir
Registro completo de metadados
Campo DCValorIdioma
dc.contributor.authorBarroso, Daniel Holanda-
dc.contributor.authorFalcão, Sarah de Athayde Couto-
dc.contributor.authorMotta, Jorgeth de Oliveira Carneiro da-
dc.contributor.authorSantos, Laís Sevilha dos-
dc.contributor.authorTakano, Gustavo Henrique Soares-
dc.contributor.authorGomes, Ciro Martins-
dc.contributor.authorFavali, Cecília Beatriz Fiuza-
dc.contributor.authorLima, Beatriz Dolabela de-
dc.contributor.authorSampaio, Raimunda Nonata Ribeiro-
dc.date.accessioned2019-02-12T11:20:59Z-
dc.date.available2019-02-12T11:20:59Z-
dc.date.issued2018-05-11-
dc.identifier.citationBARROSO, Daniel Holanda et al. PD-L1 may mediate T-cell exhaustion in a case of early diffuse Leishmaniasis caused by Leishmania (L.) amazonensis. Frontiers in Immunology, v. 9, article 1021, May 2018. DOI: https://doi.org/10.3389/fimmu.2018.01021. Disponível em: https://www.frontiersin.org/articles/10.3389/fimmu.2018.01021/full. Acesso em: 12 fev. 2019.pt_BR
dc.identifier.urihttp://repositorio.unb.br/handle/10482/33985-
dc.language.isoInglêspt_BR
dc.publisherFrontierspt_BR
dc.rightsAcesso Abertopt_BR
dc.titlePD-L1 may mediate T-cell exhaustion in a case of early diffuse Leishmaniasis caused by Leishmania (L.) amazonensispt_BR
dc.typeArtigopt_BR
dc.subject.keywordLeishmaniose tegumentarpt_BR
dc.subject.keywordLeishmania (Leishmania) amazonensispt_BR
dc.subject.keywordCélulaspt_BR
dc.subject.keywordEnzimaspt_BR
dc.subject.keywordCitometriapt_BR
dc.rights.licenseCopyright © 2018 Barroso, Falcão, Motta, Sevilha-Santos, Takano, Gomes, Favali, de Lima and Sampaio. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.pt_BR
dc.identifier.doihttps://doi.org/10.3389/fimmu.2018.01021pt_BR
dc.description.abstract1Introduction: Diffuse cutaneous leishmaniasis (DCL) is a rare disease form associated with Leishmania (L.) amazonensis in South America. It represents the “anergic” pole of American Tegumentary Leishmaniasis, and the explanation for its resistance to treatment remains elusive. We aimed to study some possible immunological mechanisms involved in the poor DCL treatment response by evaluating some cell surface molecules obtained from a patient with DCL by flow cytometry. Case presentation: A 65-year-old DCL patient who initially failed to respond to the standard treatment for the disease showed vacuolated macrophages filled with amastigotes in lesion biopsy, and L. (L.) amazonensis was identified through ITS1PCR amplification. The Leishmania skin test and indirect immunofluorescence analysis revealed negative results. Peripheral blood from the patient was collected after a few months of treatment, when the patient presented with no lesion. Peripheral blood mononuclear cells were analyzed ex vivo and in vitro after 48 h of stimulation with soluble L. (L.) amazonensis antigen (SLA). Cell death, surface molecules, and intracellular molecules, such as IFN-γ and granzyme B, were analyzed in the cells using flow cytometry. Analysis of the surface markers showed an increased expression of the inhibitory molecule programmed death ligand 1 (PD-L1) in the monocytes restimulated with SLA (approximately 65%), whereas the negative controls were 35% positive for PD-L1. Conversely, compared with the negative controls, we observed a decrease in CD4+IFN-γ+ T cells (8.32 versus 1.7%) and CD8+IFN-γ+ T cells (14% versus 1%). We also observed a relevant decrease in the granzyme B levels in the CD8+ T cells, from 31% in the negative controls to 5% after SLA restimulation. Conclusion: The dysfunctional activation of PD-L1 inhibitory pathway after Leishmania antigen stimulation and reduced levels of IFN-gamma and granzyme B-producing cells could be closely related to unresponssiveness to standard drug treatment of DCL patient.pt_BR
dc.description.unidadeFaculdade de Medicina (FMD)-
Aparece nas coleções:Artigos publicados em periódicos e afins

Mostrar registro simples do item Visualizar estatísticas



Os itens no repositório estão protegidos por copyright, com todos os direitos reservados, salvo quando é indicado o contrário.